Table 3.
Number of comorbid chronic conditions | |||||
---|---|---|---|---|---|
1 n = 376 B (95 % CI)* |
2 n = 317 B (95 % CI)* |
3 n = 235 B (95 % CI)* |
4 or more n = 387 B (95 % CI)* |
P value | |
MCS unadjusted | −0.54 (−1.66 to 0.57) | −0.71 (−1.91 to 0.49) | −1.94 (−3.28 to −0.60) | −4.29 (−5.65 to −2.92) | <0.001 |
MCS adjusted** | −0.58 (−1.71 to 0.54) | −0.60 (−1.83 to 0.63) | −1.70 (−3.11 to −0.29) | −3.87 (−5.36 to −2.38) | <0.0001 |
PCS unadjusted | −2.68 (−3.91 to −1.45) | −5.95 (−7.34 to −4.56) | −10.27 (−11.72 to −8.82) | −15.39 (−16.76 to −14.03) | <0.001 |
PCS adjusted** | −2.36 (−3.56 to −1.17) | −4.98 (−6.35 to −3.61) | −8.91 (−10.37 to −7.46) | −13.06 (−14.47 to −11.65) | <0.0001 |
* Reference group is number of patients (n=361) without any comorbid chronic condition
** Adjusted for age, sex, duration of diabetes, HbA1c, low-density lipoprotein cholesterol, systolic blood pressure, body mass index, insulin use, current smoking and physical activity